Resumen
La epidemia iniciada en diciembre del 2019 en Wuhan, China, ha captado la atención de la comunidad científica internacional debido a la gran cantidad de afectados. El microorganismo fue categorizado como el SARS-CoV2, y su enfermedad asociada, COVID-19.
Actualmente, preocupa la cantidad de información sin sustento científico que circula, la baja adherencia a las recomendaciones realizadas para minimizar la transmisión y la poca experiencia/conocimiento de los profesionales de enfermería en el manejo de este tipo de patologías.
Lo anterior, motivó la realización de la presente revisión narrativa, la cual se centró en las bases de datos Pubmed, ScienceDirect y páginas oficiales de organismos como la Organización Mundial de la Salud y los Centros para el Control y Prevención de Enfermedades.
Citas
Tyrrell DA, Bynoe ML. Cultivation
of viruses from a high proportion of
patients with colds. Lancet. 1996;
(7428): 76–77. doi: 10.1016/s0140-
(66)92364-6.
Sohrabi C, Alsafi Z, O´Neil N, Khan
M, Kerwan A, Al-Jabir A, et al.
World Health Organization declares
global emergency: A review of the
novel coronavirus (COVID19). Int J Surg. 2020; 76: 71-76. doi:
1016/j.ijsu.2020.02.034.
Sun P, Lu X, Xu C, Sun W, Pan B.
Understanding of COVID-19 based
on current evidence. J Med Virol.
doi: 10.1002/jmv.25722.
The Harvard Gazette. Coronavirus
cases hit 17,400 and are likely to
surge [Consultado 15 de Marzo
. Disponible en:
https://news.harvard.edu/gazette/stor
y/2020/02/as-confirmed-cases-ofcoronavirus-surge-path-growsuncertain/
Tesini B. Coronavirus y síndromes
respiratorios agudos (COVID-19,
MERS y SARS) [Consultado 17 de
Marzo 2020]. Disponible en:
https://www.msdmanuals.com/es/pr
ofessional/enfermedadesinfecciosas/virusrespiratorios/coronavirus-ys%C3%ADndromes-respiratoriosagudos-covid-19,-mers-y-sars
Zhong NS, Zheng BJ, Li YM, Poon
LL, Xie ZH, Chan KH, et al.
Epidemiology and cause of severe
acute respiratory syndrome (SARS)
in Guangdong, People's Republic of
China, in February, 2003. Lancet.
; 362(9393): 1353-1358. doi:
1016/S0140-6736(03)14630-2.
Zaki AM, van Boheemen S,
Bestebroer TM, Osterhaus AD,
Fouchier RA. Isolation of a novel
coronavirus from a man with
pneumonia in Saudi Arabia. N Engl J
Med. 2012; 367: 1814–1820. doi:
1056/NEJMoa1211721.
Aguilera R. ¿Revisión sistemática,
revisión narrativa o metaanálisis?
Rev. Soc. Esp. Dolor. 2014; 21(6):
-360. doi: 10.4321/S1134-
Rother E. Revisão sistemática X
revisão narrativa. Acta paulista de
enfermagem. 2007; 20(2): 5-6.
Zhou P, Yang XL, Wang XG, Hu B,
Zhang L, Zhang W, et al. A
pneumonia outbreak associated with
a new coronavirus of probable bat
origin. Nature. 2020; 579: 270-273.
doi: 10.1038/s41586-020-2012-7.
Cascella M, Rajnik M, Cuomo A,
Dulebohn S, di Napoli R. Features,
Evaluation and Treatment
Coronavirus (COVID-19). Treasure
Island (FL): StatPearls Publishing,
Murillo-Godinez G. Las gotitas de
Flügge. Rev Med Inst Mex Seguro
Soc. 2009; 47(3): 290.
Cai J, Sun W, Huang J, Gamber M,
Wu J, He G. Indirect Virus
Transmission in Cluster of COVID19 Cases, Wenzhou, China, 2020.
Emerg Infect Dis. 2020; 26(6). doi:
3201/eid2606.200412.
Ridenhour B, Kowalik JM, Shay
DK. Unraveling R0: Considerations
for Public Health Applications. Am J
Public Health. 2014; 104: e32–e41.
doi: 10.2105/AJPH.2013.301704.
Li Q, Guan X, Wu P, Wang X, Zhou
L, Tong Y, et al. Early Transmission
Dynamics in Wuhan, China, of
Novel Coronavirus-Infected
Pneumonia. N Engl J Med. 2020.
doi: 10.1056/NEJMoa2001316.
Gu J., Han B., Wang J. COVID-19:
Gastrointestinal manifestations and
potential fecal-oral transmisión.
Gastroenterology. 2020. doi:
j.gastro.2020.02.054.
Chan JF, Yuan S, Kok KH, KaiWang K, Chu H, Yang J, et al. A
familial cluster of pneumonia
associated with the 2019 novel
coronavirus indicating person‐to‐
person transmission: a study of a
family cluster. Lancet. 2020;
(10223): 514-523. doi:
1016/S0140-6736(20)30154-9.
Guan W, Ni Z, Hu Y, Liang W, Ou
C, He J, et al. Clinical Characteristics
of Coronavirus Disease 2019 in
China. N Engl J Med. 2020. doi:
1056/NEJMoa2002032.
Wang W, Tang J, Wei F. Updated
understanding of the outbreak of
novel coronavirus (2019-
nCoV) in Wuhan, China. Journal of
Medical Virology. 2020; 92(4): 441-
doi: 10.1002/jmv.25689.
Huang C, Wang Y, Li X, Ren L,
Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel
coronavirus in Wuhan, China.
Lancet. 2020; 395(10223): 497-506.
doi: 10.1016/S0140-6736(20)30183-
Tian S, Hu N, Louu J, Chen K, Kang
X, Xiang Z, et al. Characteristics of
COVID-19 infection in Beijing. J
infect. 2020. doi:
1016/j.jinf.2020.02.018
Velavan T, Meyer C. The COVID-19
epidemic. Trop Med Int Health.
; 25(3): 278-280. doi:
1111/tmi.13383.
Wang J, Zhou M, Liu F. Exploring
the reasons for healthcare workers
infected with novel coronavirus
disease 2019 (COVID-19) in China.
J Hosp Infect. 2020. doi:
1016/j.jhin.2020.03.002.
Ye G, Pan Z, Pan Y, Deng Q, Chen
L, Li J, et al. Clinical characteristics
of severe acute respiratory syndrome
coronavirus 2 reactivation. J Infect.
doi:
1016/j.jinf.2020.03.001.
Hamming I, Timens W, Lely AT,
Navis G, van Goor H. Tissue
distribution of ACE2 protein, the
functional receptor for SARS
coronavirus. A first step in
understanding SARS pathogenesis.
; 203(2): 631-637. doi:
1002/path.1570
Fang L, Karakiulakis G, Roth M. Are
patients with hypertension and
diabetes mellitus at increased risk for
COVID-19 infection? Lancet. 2020.
doi: 10.1016/S2213-2600(20)30116-
Soler MJ, Lloveras J, Batle D.
Enzima conversiva de la
angiotensiva 2 y su papel emergente
en la regulación del sistema reninaangiotensina. Med Clín (Barc). 2008;
(6): 230-236.
Zhao Y, Zhao Z, Wang Y, Zhou Y,
Ma Y, Zuo W. Single-cell RNA
expression profiling of ACE2, the
putative receptor of Wuhan 2019-
nCov. bioRxiv. 2020. doi:
1101/2020.01.26.919985.
Cai H. Sex difference and smoking
predisposition in patients with
COVID-19. Lancet. 2020. doi:
1016/S2213-2600(20)30117-X
Organización Mundial de la Salud
(OMS). Novel Coronavirus
(COVID-19) situation [Consultado
de Marzo 2020]. Disponible en:
https://experience.arcgis.com/experi
ence/685d0ace521648f8a5beeeee1b
cd
Gimbe – Evidence for Health.
Epidemia Coronavirus [Consultado 21 de Marzo 2020]. Disponible en:
https://coronavirus.gimbe.org/
National Institutes Of Health. NIH
clinical trial of investigational
vaccine for COVID-19 begins
[Consultado 17 de Marzo 2020].
Disponible en:
Li H, Wang YM, Xu JY, Cao B.
[Potential antiviral therapeutics for
Novel Coronavirus]. Zhonghua
Jie He He Hu Xi Za Zhi. 2020; 43(3):
-172. doi:
3760/cma.j.issn.1001-
2020.03.004.
Gordon CJ, Tchesnokov EP, Feng
JY, Porter DP, Gotte M. The antiviral
compound remdesivir potently
inhibits RNA-dependent RNA
polymerase from Middle East
respiratory syndrome coronavirus.
JBC. 2020. doi:
1074/jbc.AC120.013056.
National Library of Medicine –
Clinical Trials. Favipiravir
Combined With Tocilizumab in the
Treatment of Corona Virus Disease
[Consultado 21 de Marzo
. Disponible en:
clinicaltrials.gov/ct2/show/NCT043
Wang T, Du Z, Zhu F, Cao Z, An Y,
Gao Y, et al. Comorbidities and
multi-organ injuries in the treatment
of COVID-19. Lancet. 2020. doi:
1016/S0140-6736(20)30558-4.
Wiley K, Lubejko B. Psychosocial
Support for Patients With Cancer
During COVID-19 [Consultado 18
de Marzo 2020]. Disponible en:
https://voice.ons.org/news-andviews/psychosocial-support-forpatients-with-cancer-during-covid19
Center for Disease Control and
Prevention. What Healthcare
Personnel Should know about Caring
for Patients with Confirmed or
Possible COVID-19 Infection
[Consultado 17 de Marzo 2020].
Disponible en:
https://www.cdc.gov/coronavirus/20
-ncov/hcp/caring-forpatients.html
Center for Disease Control and
Prevention. Interim Infection
Prevention and Control
Recommendations for Patients with
Suspected or Confirmed Coronavirus
Disease 2019 (COVID-19) in
Healthcare Settings [Consultado 17
de Marzo 2020]. Disponible en:
https://www.cdc.gov/coronavirus/20
-ncov/infection-control/controlrecommendations.html
Graham C, Dela Cruz C, Cao B,
Pasnick S, Jamil S. Novel Wuhan
(2019-nCoV) Coronavirus. Am J
Respir Crit Care Med. 2020; 201(4):
-8. doi: 10.1164/rccm.2014P7.
Verbeek JH, Ijaz S, Mischke C,
Ruotsalainen JH, Mäkelä E,
Neuvonen K, et al. Personal
protective equipment for preventing
highly infectious diseases due to
exposure to contaminated body
fluids in healthcare staff. Cochrane
Database of Systematic Reviews.
; 4, Art. No.: CD011621. doi:
1002/14651858.CD011621.pub2.
Wang J, Liu F, Tan JBX, Harbarth S,
Pittet D, Zingg W. Implementation
of infection prevention and control in
acute care hospitals in Mainland
China - a systematic review.
Antimicrob Resist Infect Control.
; 8: 32. doi: 10.1186/s13756-
-0481-y.
Infobae. Terapias intensivas al límite
en la pandemia: cuántas camas
disponibles hay y cuánto cuestan por
día [Consultado 21 de Marzo 2020]. Disponible en:
https://www.infobae.com/coronavir
us/2020/03/18/terapias-intensivasal-limite-en-la-pandemia-cuantascamas-disponibles-hay-y-cuantocuesta-por-dia
Clarín. Los números de la pandemia
Coronavirus en la Argentina:
confirmaron otros 30 casos y
ascienden a 158 los infectados
[Consultado 21 de Marzo 2020].
Disponible en:
https://www.clarin.com/sociedad/co
ronavirus-argentina-confirmaron13-casos-capital-aguarda-nuevoparte-nacional_0_yKT2dQZPb.html
Organización Mundial de la Salud.
Preguntas y respuestas sobre la
enfermedad por coronavirus
(COVID-19). [Consultado 21 de
Marzo 2020]. Disponible en:
https://www.who.int/es/emergencies
/diseases/novel-coronavirus2019/advice-for-public/q-acoronaviruses
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Derechos de autor 2020 Carlos Canova-Barrios, Samanta Salvador